ATC code V08

ATC code V08 Contrast media is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup V08 is part of the anatomical group V Various.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV08.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

V08A X-ray contrast media, iodinated

V08AA Water-soluble, nephrotropic, high osmolar X-ray contrast media

V08AA01 Diatrizoic acid

V08AA02 Metrizoic acid

V08AA03 Iodamide

V08AA04 Iotalamic acid

V08AA05 Ioxitalamic acid

V08AA06 Ioglicic acid

V08AA07 Acetrizoic acid

V08AA08 Iocarmic acid

V08AA09 Methiodal

V08AA10 Diodone

V08AB Water-soluble, nephrotropic, low osmolar X-ray contrast media

V08AB01 Metrizamide

V08AB02 Iohexol

V08AB03 Ioxaglic acid

V08AB04 Iopamidol

V08AB05 Iopromide

V08AB06 Iotrolan

V08AB07 Ioversol

V08AB08 Iopentol

V08AB09 Iodixanol

V08AB10 Iomeprol

V08AB11 Iobitridol

V08AB12 Ioxilan

V08AC Water-soluble, hepatotropic X-ray contrast media

V08AC01 Iodoxamic acid

V08AC02 Iotroxic acid

V08AC03 Ioglycamic acid

V08AC04 Adipiodone

V08AC05 Iobenzamic acid

V08AC06 Iopanoic acid

V08AC07 Iocetamic acid

V08AC08 Sodium iopodate

V08AC09 Tyropanoic acid

V08AC10 Calcium iopodate

V08AD Non-watersoluble X-ray contrast media

V08AD01 Ethyl esters of iodised fatty acids

V08AD02 Iopydol

V08AD03 Propyliodone

V08AD04 Iofendylate

V08B X-ray contrast media, non-iodinated

V08BA Barium sulfate containing X-ray contrast media

V08BA01 Barium sulfate with suspending agents

V08BA02 Barium sulfate without suspending agents

V08C Magnetic resonance imaging contrast media

V08D Ultrasound contrast media

V08DA Ultrasound contrast media

V08DA01 Perflutren, human albumin microspheres

V08DA02 Microparticles of galactose

V08DA03 Perflenapent

V08DA04 Perflutren, phospholipid microspheres

V08DA05 Sulfur hexafluoride, phospholipid microspheres

V08DA06 Perflubutane, phospholipid microspheres

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code V08". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QV08". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code V08". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QV08". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

ATC code V: Various
V01 Allergens V03 All other therapeutic products V04 Diagnostic agents V06 General nutrients V07 All other non-therapeutic products V08 Contrast media V09 Diagnostic radiopharmaceuticals V10 Therapeutic radiopharmaceuticals V20 Surgical dressings
Other ATC codes
A B C D G H QI J L M N P R S V